Cetera Investment Advisers Has $5.74 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Cetera Investment Advisers increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 73,713 shares of the company’s stock after buying an additional 5,239 shares during the period. Cetera Investment Advisers’ holdings in GE HealthCare Technologies were worth $5,744,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Shell Asset Management Co. increased its holdings in shares of GE HealthCare Technologies by 60.4% during the fourth quarter. Shell Asset Management Co. now owns 19,917 shares of the company’s stock valued at $1,540,000 after acquiring an additional 7,500 shares in the last quarter. Logan Capital Management Inc. increased its stake in GE HealthCare Technologies by 21.2% during the 4th quarter. Logan Capital Management Inc. now owns 1,488 shares of the company’s stock valued at $115,000 after purchasing an additional 260 shares in the last quarter. Elo Mutual Pension Insurance Co raised its holdings in GE HealthCare Technologies by 5.0% during the fourth quarter. Elo Mutual Pension Insurance Co now owns 35,874 shares of the company’s stock worth $2,774,000 after buying an additional 1,707 shares during the last quarter. XML Financial LLC bought a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $243,000. Finally, Boyar Asset Management Inc. acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at about $339,000. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently weighed in on GEHC. Evercore ISI upped their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their target price for the company from $84.00 to $74.00 in a report on Thursday, September 26th. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, Stifel Nicolaus lifted their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $94.23.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $90.69 on Wednesday. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.55. The firm’s 50-day simple moving average is $86.57 and its two-hundred day simple moving average is $83.27. The firm has a market cap of $41.40 billion, a price-to-earnings ratio of 26.52, a P/E/G ratio of 3.40 and a beta of 1.18. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter in the prior year, the business earned $0.92 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up .5% on a year-over-year basis. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. GE HealthCare Technologies’s payout ratio is 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.